Gorlin Syndrome Market
Gorlin Syndrome, also known as Nevoid basal cell carcinoma (NBCCS) or Gorlin-–Goltz syndrome, is an infrequent multisystemic disease that is inherited in an autosomal dominant way and shows the high level of penetrance and variable expressiveness.
It has also been observed that the estimated prevalence of NBCCS has no observed sex predilection i.e., the male-to-female ratio is 1:1.
According to the National Institute of Health (NIH), United States, Gorlin syndrome affects an estimated 1 in 31,000 people. While more than 1 million new cases of basal cell carcinoma are diagnosed each year in the United States, less than 1% of these skin cancers are related to Gorlin syndrome.
As per the study conducted by M. Lorenzo et al., “the estimated prevalence of Gorlin Syndrome varies from 1/57,000 to 1/256,000”.
For more detailed information on Gorlin Syndrome Market, visit:
https://www.delveinsight.com/report-store/gorlin-syndrome-market
